News

Press Releases

Hogan Lovells acts for Recordati on US$300 million acquisition of commercial rights to three medicines from AstraZeneca

London, 25 May 2017 – Hogan Lovells, the global law firm, has advised Italian headquartered Recordati S.p.A ("Recordati") on a US$300 million acquisition of commercial rights to three ...

Loading data